MedTrace Logo

CorEvitas Inflammatory Bowel Disease (IBD) Registry

NCT03162549 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 2287

Last updated 2025-10-02

No results posted yet for this study

Summary

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Conditions

  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • CorEvitas

    lead NETWORK

Principal Investigators

  • Jeffrey Greenberg, MD · CorEvitas, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-27
Primary Completion
2100-12-31
Completion
2100-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162549 on ClinicalTrials.gov